Doctor profile · Federal record
Dr. Jeffrey Scales, M.D.
Dermatology Physician (CMS: Dermatology) · Durham, NC
- NPI 1497818397
- Accepts Medicare
- 43 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6216 Fayetteville RD, Suite 102
Durham, NC 277136287
(919) 484-9551
fax (919) 484-0667
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1983 — 43 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- North Carolina #9400629
- Medicaid
- NC #8910352
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1497818397. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
790
Distinct HCPCS
10
Medicare allowed
$57,284
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 203 | 141 | $85 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 89 | 22 | $6 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 81 | 81 | $105 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 80 | 54 | $120 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 73 | 27 | $1 | |
11102 |
Biopsy of related skin growth, first growth | 70 | 62 | $94 | |
11901 |
Injection into skin growth, more than 7 growths | 65 | 22 | $66 | |
17000 |
Destruction of precancer skin growth, 1 growth | 34 | 32 | $50 | |
11103 |
Biopsy of related skin growth, each additional growth | 32 | 21 | $47 | |
11104 |
Punch biopsy, first skin growth | 20 | 20 | $118 |
In context: peer comparison
Among 13 peers in this city , average services per provider: 186. This provider delivers 4.2× the peer median.Open Payments
Industry payments received
All-time total
$50,831
Transactions
214
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Galderma Laboratories, L.P. | 31 | $27,506.66 | |
| PFIZER INC. | 19 | $10,910.98 | |
| Dermavant Sciences, Inc. | 33 | $9,540.53 | |
| ABBVIE INC. | 32 | $785.47 | |
| Janssen Biotech, Inc. | 11 | $306.96 | |
| E.R. Squibb & Sons, L.L.C. | 16 | $291.44 | |
| Amgen Inc. | 10 | $276.72 | |
| GENZYME CORPORATION | 12 | $238.22 | |
| Lilly USA, LLC | 12 | $234.11 | |
| Regeneron Healthcare Solutions, Inc. | 14 | $196.47 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $156.12 | |
| Arcutis Biotherapeutics, Inc. | 12 | $149.31 | |
| UCB, Inc. | 3 | $79.91 | |
| Incyte Corporation | 2 | $70.98 | |
| Novartis Pharmaceuticals Corporation | 1 | $40.31 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
472
Patients
261
Total drug cost
$312,130
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 114 | 81 | $2,282 |
| Hydrocortisone | Generic | 113 | 67 | $1,580 |
| Clobetasol Propionate | Generic | 64 | 39 | $4,996 |
| Ketoconazole | Generic | 28 | 18 | $684 |
| Dupixent Syringe (Dupilumab) | Brand | 21 | 0 | $79,169 |
| Prednisone | Generic | 20 | 16 | $73 |
| Dupixent Pen (Dupilumab) | Brand | 19 | 0 | $73,947 |
| Halobetasol Propionate | Generic | 19 | 14 | $1,118 |
| Ssd (Silver Sulfadiazine) | Brand | 18 | 12 | $430 |
| Humira(Cf) Pen (Adalimumab) | Brand | 17 | 0 | $147,348 |
Frequently asked questions
What is Dr. Jeffrey Scales's medical specialty?
Dr. Jeffrey Scales practices Dermatology Physician in Durham, NC.
Where does Dr. Jeffrey Scales practice?
Dr. Jeffrey Scales practices at 6216 Fayetteville RD, Durham, NC 277136287. Office phone: 9194849551.
What is Dr. Jeffrey Scales's NPI?
Dr. Jeffrey Scales's National Provider Identifier (NPI) is 1497818397, issued by NPPES.
Does Dr. Jeffrey Scales accept Medicare assignment?
Yes. Dr. Jeffrey Scales accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jeffrey Scales commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); New patient office or other outpatient visit (HCPCS 99203). Source: CMS Medicare Physician & Other Practitioners file.